U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Increased susceptibility to spontaneous sister chromatid exchange

MedGen UID:
869182
Concept ID:
C4023604
Cell or Molecular Dysfunction
HPO: HP:0010998

Definition

An increase in the number of spontaneous sister chromatid exchanges observed in cell culture of lymphocytes or other cells. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVIncreased susceptibility to spontaneous sister chromatid exchange

Conditions with this feature

Microcephaly, growth restriction, and increased sister chromatid exchange 2
MedGen UID:
1648384
Concept ID:
C4748176
Disease or Syndrome
MGRISCE2 is an autosomal recessive disorder characterized by intrauterine growth restriction, poor postnatal growth with short stature and microcephaly, and increased sister chromatid exchange on cell studies. The disorder results from defective DNA decatenation. The pathogenesis of the disorder is similar to that of Bloom syndrome (BLM; 210900), but patients with mutations in the TOP3A gene do not have a malar rash (summary by Martin et al., 2018). For a discussion of genetic heterogeneity of MGRISCE, see Bloom syndrome (BLM; MGRISCE1; 210900)

Recent clinical studies

Etiology

De Pascalis I, Pilato B, Mazzotta A, Dell'Endice TS, Rubini V, Simone G, Paradiso A, Aiello V, Mangia A
Oncol Rep 2015 Feb;33(2):930-4. Epub 2014 Nov 26 doi: 10.3892/or.2014.3628. PMID: 25434423
Bajnóczky K, Khezri S, Kajtár P, Szücs R, Kosztolányi G, Méhes K
Cancer Genet Cytogenet 1999 Feb;109(1):79-80. doi: 10.1016/s0165-4608(98)00146-0. PMID: 9973966
Wiencke JK, Pemble S, Ketterer B, Kelsey KT
Cancer Epidemiol Biomarkers Prev 1995 Apr-May;4(3):253-9. PMID: 7606200
Jung EG, Bohnert E, Boonen H
Dermatologica 1986;173(6):297-300. doi: 10.1159/000249275. PMID: 3817241

Diagnosis

Wiencke JK, Pemble S, Ketterer B, Kelsey KT
Cancer Epidemiol Biomarkers Prev 1995 Apr-May;4(3):253-9. PMID: 7606200
Wiencke JK, Kelsey KT
IARC Sci Publ 1993;(127):265-73. PMID: 8070872

Therapy

Bajnóczky K, Khezri S, Kajtár P, Szücs R, Kosztolányi G, Méhes K
Cancer Genet Cytogenet 1999 Feb;109(1):79-80. doi: 10.1016/s0165-4608(98)00146-0. PMID: 9973966
Hsu YH, Li SY, Chiou HY, Yeh PM, Liou JC, Hsueh YM, Chang SH, Chen CJ
Mutat Res 1997 Jun;386(3):241-51. doi: 10.1016/s1383-5742(97)00007-0. PMID: 9219562
Jaspers NG, Roza-de Jongh EJ, Donselaar IG, Van Velzen-Tillemans JT, van Hemel JO, Rümke P, van der Kamp AW
Cancer Genet Cytogenet 1987 Jan;24(1):33-43. doi: 10.1016/0165-4608(87)90081-1. PMID: 3791172

Clinical prediction guides

De Pascalis I, Pilato B, Mazzotta A, Dell'Endice TS, Rubini V, Simone G, Paradiso A, Aiello V, Mangia A
Oncol Rep 2015 Feb;33(2):930-4. Epub 2014 Nov 26 doi: 10.3892/or.2014.3628. PMID: 25434423
Wiencke JK, Kelsey KT
IARC Sci Publ 1993;(127):265-73. PMID: 8070872
Jaspers NG, Roza-de Jongh EJ, Donselaar IG, Van Velzen-Tillemans JT, van Hemel JO, Rümke P, van der Kamp AW
Cancer Genet Cytogenet 1987 Jan;24(1):33-43. doi: 10.1016/0165-4608(87)90081-1. PMID: 3791172

Supplemental Content

Table of contents

    Clinical resources

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...